Annals of Clinical Biochemistry 1985-11-01

Therapeutic monitoring of the anti-anginal drug perhexiline maleate.

J D Cooper, D C Turnell, J Pilcher, D Lockhart

Index: Ann. Clin. Biochem. 22 ( Pt 6) , 614-7, (1985)

Full Text: HTML

Abstract

Patients taking oral doses of perhexiline maleate have been examined. Measurement of serum perhexiline concentrations established that different dose requirements between patients were necessary due to the different doses at which drug saturation was achieved. Measurement of serum perhexiline concentrations are essential if side-effects from the drug are to be avoided.

Related Compounds

  • Perhexiline maleat...

Related Articles:

Torsade de pointes associated with perhexiline maleate therapy.

1990-12-01

[Aust. N. Z. J. Med. 20(6) , 818-20, (1990)]

Further studies on the pharmacokinetics of perhexiline maleate in humans.

1986-01-01

[Xenobiotica 16(1) , 63-8, (1986)]

Stimulatory effect of perhexiline maleate on the basal and LHRH-stimulated luteinizing hormone release from rat pituitary cell aggregates in vitro.

1995-02-01

[Res. Commun. Mol. Pathol. Pharmacol. 87(2) , 115-23, (1995)]

A case series of concomitant treatment of perhexiline with amiodarone.

2012-04-01

[Ther. Drug Monit. 34(2) , 227-31, (2012)]

Impairment of sulfobromophthalein biliary excretion and inhibition of glutathione S-transferase activity induced by perhexiline maleate in rats.

1988-09-15

[Biochem. Pharmacol. 37(18) , 3461-5, (1988)]

More Articles...